Librium

Chlordiazepoxide hydrochloride, the active ingredient in Librium, is a benzodiazepine presented as an oral formulation for oral use. It is prescribed for anxiety disorders and for managing alcohol withdrawal syndrome. GNH USA supplies Librium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Chlordiazepoxide, a benzodiazepine that enhances GABA‑mediated inhibition, is indicated for the following conditions:

- Anxiety disorders: reduces excessive worry and tension. - Alcohol withdrawal syndrome: eases withdrawal symptoms and helps prevent seizures. - Preoperative anxiety: provides short‑term sedation before surgical procedures.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Drowsiness - Fatigue - Dizziness - Impaired coordination - Blurred vision - Memory impairment

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Paradoxical agitation or aggression - Suicidal thoughts or behavior - Allergic reactions including rash or angioedema - Stevens‑Johnson syndrome or toxic epidermal necrolysis

Before initiating therapy, consider the following safety measures:

- Dose adjustment in elderly: start with a lower dose due to increased sensitivity. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal symptoms. - Use with caution in hepatic impairment: the drug is metabolised by the liver. - Avoid concomitant CNS depressants: risk of additive sedation and respiratory depression. - Pregnancy and lactation: consult a healthcare professional; limited safety data are available. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Chlordiazepoxide can interact with several other medicines. Review the following categories:

Major Interactions (Avoid): - Opioids: additive respiratory depression. - Barbiturates: increased central nervous system depression. - Alcohol: potentiates sedative effect.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs): may increase sedation. - Antihistamines: enhanced drowsiness. - CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma levels of chlordiazepoxide.